Table 2.
References | Study, Number of patients with sarcoidosis | Number of patients with changes | Detected antibodies |
---|---|---|---|
Maddrey et al. (75) | 20 patients with sarcoidosis and chronic liver damage | 1/20 5.0% |
Antimitochondrial antibodies |
Fagan et al. (76) | 4 patients with sarcoidosis and liver damage | 4/4 | |
Stanca et al. (77) | Clinical case: patient with sarcoidosis and primary biliary cirrhosis | 1/1 | |
Weinberg et al. (78) | 34 patients with sarcoidosis | 10/34 29.4% |
Antinuclear antibodies |
2/34 5.8% |
Antibodies to double stranded DNA | ||
Kobak et al. (9, 79, 80) | 42 patients with sarcoidosis | 2/42 4.7% |
Antibodies to citrullinated cyclic peptide |
7/42 16.7% |
Rheumatoid factor | ||
Total six studies | 101 patients with sarcoidosis | 27/101 (26.7%) |
- |